Emily A Bossart
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia
Frei N, Critchley-Thorne R, Meijer S, Seldenrijk K, Ten Kate F, Pouw R, Zhang Y, Stebbins K, Bossart E, Konte K, Khoshiwal A, Bergman J. Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia. Am J Gastroenterol 2021; 116:675-682.
Jan 1, 2021Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade Dysplasia
Jan 1, 2021Am J Gastroenterol 2021; 116:675-682
Frei Nicola Fabian, Critchley-Thorne Rebecca J, Meijer Sybren L, Seldenrijk Kees A, Ten Kate Fiebo J W, Pouw Roos E, Zhang Yi, Stebbins Katelyn, Bossart Emily A, Konte Kadere, Khoshiwal Amir M, Bergman Jacques J G H M
Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
Frei N, Konte K, Bossart E, Stebbins K, Zhang Y, Pouw R, Critchley-Thorne R, Bergman J. Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis. Clin Transl Gastroenterol 2020; 11:e00244.
Jan 1, 2020Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progression in Nondysplastic Barrett's Esophagus: A Spatial-Temporal Analysis
Jan 1, 2020Clin Transl Gastroenterol 2020; 11:e00244
Frei Nicola Fabian, Konte Kadere, Bossart Emily A, Stebbins Katelyn, Zhang Yi, Pouw Roos E, Critchley-Thorne Rebecca J, Bergman Jacques J G H M